BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29568890)

  • 1. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
    Zhu F; Wu Q; Ni Z; Lei C; Li T; Shi Y
    Int J Mol Med; 2018 Jul; 42(1):228-236. PubMed ID: 29568890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
    Wada R; Akiyama Y; Hashimoto Y; Fukamachi H; Yuasa Y
    Int J Cancer; 2010 Sep; 127(5):1106-14. PubMed ID: 20020497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.
    Tong D; Zhao L; He K; Sun H; Cai D; Ni L; Sun R; Chang S; Song T; Huang C
    Oncotarget; 2016 Jun; 7(23):34845-59. PubMed ID: 27166996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
    Wang F; Li T; Zhang B; Li H; Wu Q; Yang L; Nie Y; Wu K; Shi Y; Fan D
    Biochem Biophys Res Commun; 2013 May; 434(3):688-94. PubMed ID: 23603256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
    Zhang Y; Lu Q; Cai X
    FEBS Lett; 2013 Sep; 587(18):3069-75. PubMed ID: 23932924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.
    Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
    Wu Q; Yang Z; An Y; Hu H; Yin J; Zhang P; Nie Y; Wu K; Shi Y; Fan D
    Cell Death Dis; 2014 Mar; 5(3):e1144. PubMed ID: 24675462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.
    Wu Q; Yang Z; Xia L; Nie Y; Wu K; Shi Y; Fan D
    Oncotarget; 2014 Nov; 5(22):11552-63. PubMed ID: 25344911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
    Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
    Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C; Shan Z; Li C; Yang L
    Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W; Xu Z; Zhang M; Zuo Y
    Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
    Li CL; Nie H; Wang M; Su LP; Li JF; Yu YY; Yan M; Qu QL; Zhu ZG; Liu BY
    Oncol Rep; 2012 Jun; 27(6):1960-6. PubMed ID: 22426647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.
    Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
    Int J Mol Med; 2018 Apr; 41(4):1958-1966. PubMed ID: 29328428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
    Huang H; Tang J; Zhang L; Bu Y; Zhang X
    Int J Oncol; 2018 Dec; 53(6):2769-2779. PubMed ID: 30320370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.
    Goto K; Ishikawa S; Honma R; Tanimoto K; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncogene; 2016 Jul; 35(27):3598-606. PubMed ID: 26640143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.